comparison of 14 days hybrid therapy with 14 days standard triple therapy on erradication of H.pylori in hemodialysis patients

Mazandaran University of Medical Science and Health Services0 个研究点目标入组 60 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•inclusion criteria: 18 - 80 years patients on hemodialysis for at least 3 months who have GI symptoms such as dyspepsia or epigasteric pain , or referred for evaluation of H.pylori infection before renal transplantation , or for evaluation of Iron Defficiency Anemia , endoscopy has done and H.pylori confirmed by at least one positive test out of the following : rapid urease test (RUT) ,or histology , or stool antigen test .
•Exclusion criteria :
•-age less than 18 yr and more than 80 yr .
•-advanced chronic disease or any other pathology that prevents attending controls and fallow up .
•-allergy to any of the antibiotics in the treatment .
•-previous gastric surgery
•-pregnancy and lactation
•-previous eradication treatment
•consumption of antibiotics or bismuth salts during the last 4 weeks .
•- concurrent use of anticoagulant or ketoconazole and or steroids
•-severe heart failure include myocardial infarction or EF < 30 that confirmed by echocardiogram
•-incooperative pationt

发起方

Mazandaran University of Medical Science and Health Services